You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ARG1-D

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Arginase I Deficiency, Hyperargininemia Trial (Pegzilarginase)

Not yet recruiting
  • Arginase I Deficiency
  • Hyperargininemia
  • (no location specified)
Jan 6, 2023

Vitamin D Deficiency Trial in London (Vitamin D3 supplement)

Recruiting
  • Vitamin D Deficiency
  • Vitamin D3 supplement
  • London, Lobdon, United Kingdom
    St Mary's University Twickenham
Mar 24, 2023

Cystatin D Fibrinogen Like Protein 1

Not yet recruiting
  • Fibrinogen Like Protein 1
  • ELISA TEST
  • (no location specified)
Jun 26, 2023

Drug Resistant Epilepsy Trial in Medan (Cholecalciferol, )

Not yet recruiting
  • Drug Resistant Epilepsy
  • Medan, North Sumatra, Indonesia
    Faculty of Medicine Universitas Sumatera Utara
Sep 21, 2023

Vitamin D Deficiency Trial in Jakarta Pusat (Cholecalciferol)

Active, not recruiting
  • Vitamin D Deficiency
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Cipto Mangunkusumo National Center General Hospital
Sep 22, 2023

Mild Intellectual Disability, Borderline Intellectual Functioning Trial in San Francisco (D-kit/EF1, Sham group program)

Not yet recruiting
  • Mild Intellectual Disability
  • Borderline Intellectual Functioning
  • D-kit/EF1
  • Sham group program
  • San Francisco, California
    UCSF Nancy Friend Pritzker Psychiatry Building
Jun 27, 2023

Vitamin D, HbA1c and Vitamin B12 Levels in Patients

Completed
  • Serum HbA1c and Vitamin D, Vitamin B12 Values in Periodontal Diseases
  • HbA1c, Vitamin D, Vitamin B12
  • Niğde, Turkey
    Nigde Omer Halisdemir University, Dentistry Faculty, Periodontol
Feb 23, 2023

Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial (procedure, dietary

Not yet recruiting
  • Stage I Prostate Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Apr 20, 2023

Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia Trial

Not yet recruiting
  • Chronic Lung Disease of Prematurity
  • +2 more
  • Recombinant fragment of human surfactant protein D (rfhSP-D)
  • (no location specified)
Jun 6, 2023

Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)

Not yet recruiting
  • Unresectable Intrahepatic Cholangiocarcinoma
  • (no location specified)
Feb 17, 2023

Acne Vulgaris, Vitamin D Trial in Jakarta Pusat (combination oral and topical vitamin D, oral and topical cholecalciferol, oral

Enrolling by invitation
  • Acne Vulgaris
  • Vitamin D
  • combination oral and topical vitamin D
  • +2 more
  • Jakarta Pusat, DKI Jakarta, Indonesia
    RSUPN Dr. Cipto Mangunkusumo
Mar 4, 2023

Type 1 Diabetes, Autoimmune Diabetes Trial in Buenos Aires (Non-hybrid closed-loop system with ARG algorithm)

Completed
  • Type 1 Diabetes
  • Autoimmune Diabetes
  • Non-hybrid closed-loop system with ARG algorithm
  • Buenos Aires, Argentina
    Hospital Italiano de Buenos Aires
Jul 28, 2021

PGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of Glycosylation Trial (AVTX-801)

Not yet recruiting
  • PGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of Glycosylation
  • (no location specified)
Jan 12, 2023

Asthma Trial in Canada (Vitamin D, Placebo)

Recruiting
  • Asthma
  • Vitamin D
  • Placebo
  • Vancouver, British Columbia, Canada
  • +8 more
Jan 30, 2023

Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain

Recruiting
  • Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
  • Quantitative Real Time Polymerase chain reaction (qRT-PCR)
  • ELISA and colorimeter
  • Assiut, Egypt
    Biochemistry department,Faculty of medicine
Oct 10, 2023

Healthy Volunteers (Diabetes, Type 2) Trial in Harrow (Semaglutide B, 1.34 mg/mL, Semaglutide D, 1.0 mg/mL)

Completed
  • Healthy Volunteers (Diabetes Mellitus, Type 2)
  • Semaglutide B, 1.34 mg/mL
  • Semaglutide D, 1.0 mg/mL
  • Harrow, Middlesex, United Kingdom
    Novo Nordisk Investigational Site
Jan 29, 2023

MDD Trial in Calgary (D-cycloserine, Transcranial Magnetic Stimulator)

Recruiting
  • Major Depressive Disorder
  • Calgary, Alberta, Canada
    University of Calgary
Feb 16, 2023

Unresectable Hepatocellular Carcinoma Trial in Nanchang (D-TACE, HAIC, Lenvatinib)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Nanchang, Jiangxi, China
    The Second Affiliated Hospital of Nanchang University
Oct 14, 2022

Pre-frail Elderly Trial in Jakarta (Cholecalciferol, Placebo)

Completed
  • Pre-frail Elderly
  • Jakarta, DKI Jakarta, Indonesia
    Cipto Mangunkusumo General Hospital
Jan 25, 2023

Food Allergy Trial in Melbourne (Vitamin D, )

Active, not recruiting
  • Food Allergy
  • Vitamin D
  • placebo
  • Melbourne, Victoria, Australia
    Murdoch Childrens Research Institute
Nov 7, 2022

Burosumab and 1-25 (OH) Vitamin D on Human Osteoclasts

Completed
  • Hypophosphatemic Rickets
  • blood sample
  • Bron, France
  • +2 more
Oct 5, 2022

Cervical Cancer Trial in Beijing (BL-B01D1, SI-B003)

Not yet recruiting
  • Cervical Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Aug 16, 2023

Small Cell Lung Cancer Trial in Changchun (BL-B01D1, SI-B003)

Not yet recruiting
  • Small Cell Lung Cancer
  • Changchun, Jilin, China
    Jilin Cancer Hospital
Jun 21, 2023

Pregnancy Complications, Maternal Obesity Trial in Sultangazi (Biomarker measurement of pannexin-1 and gasdermin-D)

Completed
  • Pregnancy Complications
  • Maternal Obesity
  • Biomarker measurement of pannexin-1 and gasdermin-D
  • Sultangazi, İstanbul, Turkey
    Haseki Training and Research Hospital
Jul 25, 2022